Atlas Trials

Stichting European Myeloma Network

11 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Stichting European Myeloma Network

RecordFirmDate
Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma (NCT06183489)Stichting European Myeloma Network2024-05-14
Phase 2 Study Applying MRD Techniques for Participants With Previously Untreated Multiple Myeloma Treated With D-VRd Prior To and After High-dose Therapy Followed by ASCT - TAURUS (NCT06189833)Stichting European Myeloma Network2023-11-23
A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma (NCT05257083)Stichting European Myeloma Network2023-10-10
A Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis (NCT04617925)Stichting European Myeloma Network2021-02-26
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients (NCT04564703)Stichting European Myeloma Network2021-02-22
COVID-19 Infection and Multiple Myeloma (NCT04492371)Stichting European Myeloma Network2020-07-01
Daratumumab Combined With Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting With Extramedullary Disease (NCT04166565)Stichting European Myeloma Network2019-10-31
A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis (NCT04131309)Stichting European Myeloma Network2019-09-23
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma (NCT03710603)Stichting European Myeloma Network2018-12-14

Track Stichting European Myeloma Network automatically

Every clearance here is in the API, with alerts when new ones post.